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where r cri and D cri are distance-to-agreement and dose difference criteria (my symbols), and ∇D is the gradient of the reference dose distribution. Where the authors define a modified dose difference,
Bakai et al. would define the index χ as
for an actual dose difference δD at a point (x,y,z), when their Eq. (6) is cast in the above terminology. In addition, Bakai et al. provided a convincing theoretical basis for the (1 + β 2 ) 1/2 factor, rather than (1 + β), in terms of the minimum distance between two surfaces in (x,y,z,D) space when measured in appropriate units.
To be fair to the authors, Bakai et al. did not actually define a modified dose difference χD cri , nor the weighting factor (1 + β 2 ) 1/2 explicitly, so the similarity could easily have been missed. I realize it is a bit unseemly to reference one's own work, but I did make that definition myself in connection with evaluating 3D dose differences. (2) Sincerely, Will Ansbacher rEfErEncEs
